Levodopa

monoamine oxidase B ; Rattus norvegicus







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30291173 Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia. 2018 Dec 1
2 24906468 Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor. 2015 Feb 1
3 23992249 Increased L-DOPA-derived dopamine following selective MAO-A or -B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation. 2013 Nov 3
4 18256746 Structural, functional, and biochemical changes in the brain during modeling of dopamine system disturbances in rats. 2007 Jul 1
5 17016505 Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L-DOPA in the rat. 2006 Nov 2
6 12907313 L-DOPA increases noradrenaline turnover in central and peripheral nervous systems. 2003 Sep 1
7 12039419 Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease. 2002 Mar 1
8 11215752 The novel type B MAO inhibitor PF9601N enhances the duration of L-DOPA-induced contralateral turning in 6-hydroxydopamine lesioned rats. 2000 1
9 9489509 The activity of MAO A and B in rat renal cells and tubules. 1998 1
10 9444560 Effect of monoamine oxidase A and B and of catechol-O-methyltransferase inhibition on L-DOPA-induced circling behavior. 1997 1
11 9620056 In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism. 1995 2
12 7867755 Chronic treatment with levodopa and/or selegiline does not affect behavioral recovery induced by fetal ventral mesencephalic grafts in unilaterally 6-hydroxydopamine-lesioned rats. 1994 Dec 2
13 2089083 Role of monoamine oxidase A and B in the deamination of newly-formed dopamine in the rat kidney. 1990 1
14 2124622 Effects of MAO-A and MAO-B selective inhibitors Ro 41-1049 and Ro 19-6327 on the deamination of newly formed dopamine in the rat kidney. 1990 Dec 1
15 3082400 Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects. 1986 Jan 2